Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial
WP Fendler, J Calais, M Eiber, RR Flavell… - JAMA …, 2019 - jamanetwork.com
Importance In retrospective studies, 68 Ga-PSMA-11 positron emission tomographic (PET)
imaging improves detection of biochemically recurrent prostate cancer compared with …
imaging improves detection of biochemically recurrent prostate cancer compared with …
[HTML][HTML] Strategies and technical challenges for imaging oligometastatic disease: Recommendations from the European Organisation for Research and Treatment of …
NM deSouza, Y Liu, A Chiti, D Oprea-Lager… - European journal of …, 2018 - Elsevier
Patients with oligometastatic disease (OMD) often have controllable symptoms, and cures
are possible. Technical improvements in surgery and radiotherapy have introduced the …
are possible. Technical improvements in surgery and radiotherapy have introduced the …
Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversies
L Lee, T Ito, RT Jensen - Expert review of anticancer therapy, 2018 - Taylor & Francis
Introduction: Recently, there have been a number of advances in imaging pancreatic
neuroendocrine tumors (panNETs), as well as other neuroendocrine tumors (NETs), which …
neuroendocrine tumors (panNETs), as well as other neuroendocrine tumors (NETs), which …
Biodistribution and first clinical results of 18F-SiFAlin-TATE PET: a novel 18F-labeled somatostatin analog for imaging of neuroendocrine tumors
H Ilhan, S Lindner, A Todica, CC Cyran, R Tiling… - European journal of …, 2020 - Springer
Abstract Introduction PET/CT using 68 Ga-labeled somatostatin analogs (SSA) targeting
somatostatin receptors (SSR) on the cell surface of well-differentiated neuroendocrine …
somatostatin receptors (SSR) on the cell surface of well-differentiated neuroendocrine …
68Ga-PSMA-11 PET/CT interobserver agreement for prostate cancer assessments: an international multicenter prospective study
WP Fendler, J Calais, M Allen-Auerbach… - Journal of Nuclear …, 2017 - Soc Nuclear Med
The interobserver agreement for 68Ga-PSMA-11 PET/CT study interpretations in patients
with prostate cancer is unknown. Methods: 68Ga-PSMA-11 PET/CT was performed in 50 …
with prostate cancer is unknown. Methods: 68Ga-PSMA-11 PET/CT was performed in 50 …
111In-pentetreotide scintigraphy versus 68Ga-DOTATATE PET: impact on Krenning scores and effect of tumor burden
Eligibility for somatostatin receptor (SSTR) radionuclide therapy uses the qualitative
Krenning score based on 111In-pentetreotide planar scintigraphy as was performed in the …
Krenning score based on 111In-pentetreotide planar scintigraphy as was performed in the …
Current concepts in 68Ga-DOTATATE imaging of neuroendocrine neoplasms: interpretation, biodistribution, dosimetry, and molecular strategies
L Bodei, V Ambrosini, K Herrmann… - Journal of Nuclear …, 2017 - Soc Nuclear Med
68Ga-DOTATATE PET/CT provides information on the location of somatostatin receptor–
expressing tumors. Integrating this imaging data effectively in patient care requires the …
expressing tumors. Integrating this imaging data effectively in patient care requires the …
[HTML][HTML] Automated liver lesion detection in 68Ga DOTATATE PET/CT using a deep fully convolutional neural network
J Wehrend, M Silosky, F Xing, BB Chin - EJNMMI research, 2021 - Springer
Background Gastroenteropancreatic neuroendocrine tumors most commonly metastasize to
the liver; however, high normal background 68 Ga-DOTATATE activity and high image noise …
the liver; however, high normal background 68 Ga-DOTATATE activity and high image noise …
[HTML][HTML] Radiolabeled somatostatin analogues for diagnosis and treatment of neuroendocrine tumors
V Ambrosini, L Zanoni, A Filice, G Lamberti, G Argalia… - Cancers, 2022 - mdpi.com
Simple Summary Neuroendocrine neoplasms (NENs) are rare and heterogeneous tumors,
presenting in often challenging clinical scenarios, and require multidisciplinary discussion …
presenting in often challenging clinical scenarios, and require multidisciplinary discussion …
Diagnosis of Zollinger–Ellison syndrome in the era of PPIs, faulty gastrin assays, sensitive imaging and limited access to acid secretory testing
DC Metz, G Cadiot, P Poitras, T Ito… - International journal of …, 2017 - Future Medicine
In recent years, the diagnosis of Zollinger–Ellison syndrome has become increasingly
controversial with several new approaches and criteria proposed, differing from the classical …
controversial with several new approaches and criteria proposed, differing from the classical …